Identification of FOXP3-negative regulatory T-like (CD4 +CD25 +CD127 low) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome

Clinical Immunology

Volumn 141, Issue 1, 2011, Pages 111-120

  Otsubo, Keisuke ^a   Kanegane, Hirokazu ^a   Kamachi, Yoshiro ^b   Kobayashi, Ichiro ^c   Tsuge, Ikuya ^d   Imaizumi, Masue ^e   Sasahara, Yoji ^f   Hayakawa, Akira ^g   Nozu, Kandai ^g   Iijima, Kazumoto ^g   Ito, Shuichi ^h   Horikawa, Reiko ^h   Nagai, Yoshinori ^a   Takatsu, Kiyoshi ^a,i   Mori, Hisashi ^a   Ochs, Hans D ^j   Miyawaki, Toshio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MIYAGI CHILDREN S HOSPITAL   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

ⁱ Toyama Prefectural Institute for Pharmaceutical Research   (Japan)

^j UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

CD127; FOXP3; Hematopoietic stem cell transplantation; Immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX); Regulatory T cells

Indexed keywords

CD4 ANTIGEN; CELL SURFACE MARKER; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; IPEX SYNDROME; POLYENDOCRINOPATHY; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD;

ADULT; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC DISEASES, X-LINKED; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MUTATION; POLYENDOCRINOPATHIES, AUTOIMMUNE; SYNDROME; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 80053130070     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.06.006     Document Type: Article

References (36)

1. Bennett C.L., Ochs H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 2001, 13:533-538.
2. Torgerson T.R., Ochs H.D. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 2007, 120:744-750.
3. Wildin R.S., Smyk-Pearson S., Filipovich A.H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Genet. 2002, 39:537-545.
4. Baud O., Goulet O., Canioni D., Le Deist F., Radford I., Rieu D., Dupuis-Girod S., Cerf-Bensussan N., Cavazzana-Calvo M., Brousse N., Fischer A., Casanova J.L. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N. Engl. J. Med. 2001, 344:1758-1762.
5. Mazzolari E., Forino C., Fontana M., D'Ippolito C., Lanfranchi A., Gambineri E., Ochs H., Badolato R., Notarangelo L.D. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant. 2005, 35:1033-1034.
6. Rao A., Kamani N., Filipovich A., Lee S.M., Davies S.M., Dalal J., Shenoy S. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 2007, 109:383-385.
7. Burroughs L.M., Torgerson T.R., Storb R., Carpenter P.A., Rawlings D.J., Sanders J., Scharenberg A.M., Skoda-Smith S., Englund J., Ochs H.D., Woolfrey A.E. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J. Allergy Clin. Immunol. 2010, 126:1000-1005.
8. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
9. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., Bricarelli F.D., Byrne G., McEuen M., Proll S., Appleby M., Brunkow M.E. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
10. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelley T.E., Saulsbury F.T., Chance P.F., Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
11. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
12. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005, 6:345-352.
13. Akdis M., Blaser K., Akdis C.A. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J. Allergy Clin. Immunol. 2005, 116:961-968.
14. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
15. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
16. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
17. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 2001, 276:37672-37679.
18. + T reg cells. J. Exp. Med. 2006, 203:1701-1711.
19. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., Solomon M., Selby W., Alexander S.I., Nanan R., Kelleher A., Fazekas de St Groth B. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 2006, 203:1693-1700.
20. Hartigan-O'Connor D.J., Poon C., Sinclair E., McCune J.M. Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 2007, 319:41-52.
21. low/- regulatory T cells express FoxP3 and suppress effector T cell proliferation and contribute to gastric cancers progression. Clin. Immunol. 2009, 131:109-118.
22. lowregulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J. Immunol. 2008, 180:6411-6420.
23. lo/- regulatory T cell function. J. Allergy Clin. Immunol. 2008, 121:1460-1466.
24. lo phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons. J. Infect. Dis. 2010, 201:331-335.
25. Kobayashi I., Shiari R., Yamada M., Kawamura N., Okano M., Yara A., Iguchi A., Ishikawa N., Ariga T., Sakiyama Y., Ochs H.D., Kobayashi K. Novel mutations of FOXP3 in two Japanese patients with immune dysregulation, polyendocrinopathy, enteropathy, X linked syndrome (IPEX). J. Med. Genet. 2001, 38:874-876.
26. Tanaka H., Suzuki K., Nakahata T., Kobayashi I., Kubota M., Ito E. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Acta Paediatr. 2004, 93:142-143.
27. + regulatory T cells and their impairment in patients with FOXP3 mutations. Clin. Immunol. 2007, 125:237-246.
28. Hashimura Y., Nozu K., Kanegane H., Miyawaki T., Hayakawa A., Yoshikawa N., Nakanishi K., Takemoto M., Iijima K., Matsuo M. Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr. Nephrol. 2009, 24:1181-1186.
29. Hannibal M.C., Torgerson T. IPEX syndrome. Gene Reviews [Internet] Oct 19 1993-2004, University of Washington, Seattle (WA), [updated 2007 Dec 12]. R.A. Pagon, T.C. Bird, C.R. Dolan, K. Stephens (Eds.).
30. Powell B.R., Buist N.R., Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J. Pediatr. 1982, 100:731-737.
31. Gavin M.A., Torgerson T.R., Houston E., deRoos P., Ho W.Y., Stray-Pederson A., Ocheltree E.L., Greenberg P.D., Ochs H.D., Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:6659-6664.
32. d'Hennezel E., Ben-Shoshan M., Ochs H.D., Torgerson T.R., Russell L.J., Lejtenyi C., Noya F.J., Jabado N., Mazer B., Piccirillo C.A. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N. Engl. J. Med. 2009, 361:1710-1713.
33. Gambineri E., Perroni L., Passerini L., Bianchi L., Doglioni C., Meschi F., Bonfanti R., Sznajer Y., Tommasini A., Lawitschka A., Junker A., Dunstheimer D., Heidemann P.H., Cazzola G., Cipolli M., Friedrich W., Janic D., Azzi N., Richmond E., Vignola S., Barabino A., Chiumello G., Azzari C., Roncarolo M.G., Bacchetta R. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J. Allergy Clin. Immunol. 2008, 122:1105-1112.
34. Bacchetta R., Passerini L., Gambineri E., Dai M., Allan S.E., Perroni L., Dagna-Bricarelli F., Sartirana C., Matthes-Martin S., Lawitschka A., Azzari C., Ziegler S.F., Levings M.K., Roncarolo M.G. Defective regulatory and effector T cell function in patients with FOXP3 mutations. J. Clin. Invest. 2006, 116:1713-1722.
35. Futatani T., Miyawaki T., Tsukada S., Hashimoto S., Kunikata T., Arai S., Kurimoto M., Niida Y., Matsuoka H., Sakiyama Y., Iwata T., Tsuchiya S., Tatsuzawa O., Yoshizaki K., Kishimoto T. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by flow cytometric analysis and its clinical application to carrier detection. Blood 1998, 91:595-602.
36. Di Nunzio S., Cecconi M., Passerini L., McMurchy A.N., Baron U., Turbachova I., Vignola S., Valencic E., Tommasini A., Junker A., Cazzola G., Olek S., Levings M.K., Perroni L., Roncarolo M.G., Bacchetta R. Wild-type FOXP3 is selectively active in CD4+CD25hi regulatory T cells of healthy female carriers of different FOXP3 mutations. Blood 2009, 114:4138-4141.